title: Hepatitis associated with micafungin use in a preterm infant.
abstract: Micafungin is an echinocandin-class antifungal agent licensed for treatment of invasive disease in adults. The optimal dosing regimens have not been established for infants. We describe a premature infant who developed hepatitis and cholestasis during micafungin therapy initiated for protracted candidemia. Practitioners should be aware of this potential adverse effect if using micafungin in young patients.
authors.affiliation: Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX 77030, USA. kyk@bcm.edu
authors.forename: K Y
authors.initials: KY
authors.lastname: King
authors.forename: M S
authors.initials: MS
authors.lastname: Edwards
authors.forename: B M
authors.initials: BM
authors.lastname: Word